Eloxx Pharmaceuticals Inc (OTCQB:ELOX)

10.20
Delayed Data
As of Apr 20
 -0.15 / -1.45%
Today’s Change
3.10
Today|||52-Week Range
10.75
+27.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-9.2M-18.1M-8.3M-21.2M
 
 
 
 
 
Depreciation349.7K177.1K93.4K39.0K
 
 
 
 
 
Total Other Cash Flow3.0M11.6M5.4M4.2M
 
 
 
 
 
Funds From Operations-5.9M-6.2M-3.5M-17.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.0M1.1M211.7K-1.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-4.9M-7.3M-3.7M-15.9M
 
 
 
 
 
 
InvestingCapital Expenditures-3.2K-122.6K0.00-237.0K
 
 
 
 
Net Assets From Acquisitions 1.3M0.000.000.00
 
 
Other Investing - Sources0.00--0.00123.0K
 
 
Net Cash Flow Investing646.9K-259.6K0.00-114.0K
 
 
 
 
 
FinancingShort Term Borrowings-2.2M0.000.00-64.0K
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale10.9M4.8M1.2M38.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing8.7M4.8M1.2M37.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash4.5M-2.8M-2.5M21.8M